Medicare AdvantageCoverageMedium impact
MA11.013c, Percutaneous Left Atrial Appendage (LAA) Closure for Non-Valvular Atrial Fibrillation (NVAF)
Independence Blue Cross·Cardiology, Cardiothoracic Surgery·Medical Policy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.013c for Percutaneous Left Atrial Appendage (LAA) Closure for Non-Valvular Atrial Fibrillation has been reissued with updates effective April 1, 2026. This policy governs coverage criteria for LAA closure procedures performed for patients with atrial fibrillation.
Action Required
By April 1, 2026: Review complete policy MA11.013c for any changes to coverage criteria, prior authorization requirements, or documentation standards for percutaneous LAA closure procedures. Update billing workflows and provider documentation requirements accordingly once full policy details are available.